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ABSTRACT 
 
Background: There are few valid clinical assessment instruments for cannabis. Self-
Efficacy, or the ability of users to resist temptation, is a central feature of social 
cognitive theory. This study outlines the development and validation of the Cannabis 
Refusal Self-Efficacy Questionnaire (CRSEQ), which measures the situational 
confidence to refuse cannabis. Method: One thousand two hundred and forty-six 
patients referred for cannabis assessment completed the CRSEQ including measures 
of cannabis consumption and dependence severity (Severity of Dependence Scale- 
Cannabis, SDS-C). The CRSEQ was subject to independent exploratory (n= 621, 
mean age 26.88, 78.6% male) and confirmatory (n= 625, mean age 27.51, 76.8% 
male) factor analysis. Results: Three factors: Emotional Relief, Opportunistic and 
Social Facilitation were identified. They provided a good statistical and conceptual fit 
for the data. Emotional Relief cannabis refusal self-efficacy was identified as most 
predictive of cannabis dependence, after controlling for cannabis consumption. 
Conclusions: The CRSEQ is recommended as a psychometrically sound and clinically 
useful measure for cannabis misuse treatment planning and assessment.  
 
Key words: cannabis; marijuana; self-efficacy; psychometric; validation 
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1. Introduction 
Cannabis remains the most commonly used illicit substance. One-third of the adult 
Australian population  have tried cannabis (Australian Institute of Health and Welfare, 
2011) with 1 in 10 reporting use during the past year (Roxburgh et al., 2010). The 
subjective reinforcing effects of cannabis include relaxation, positive mood and 
sensory enhancement, but these effects show considerable inter-individual situational 
variability (Green, et al., 2003). Significant adverse effects include injury, possible 
reduced birthweight with use in pregnancy and cognitive impairment and depression 
(Hall and Degenhardt, 2009). Chronic use incurs a significant risk of dependence with 
associated psychosocial morbidity (Copeland, et al., 2001; Feeney, et.al., 2005). A 
high prevalence of cannabis use occurs amongst presentations with psychosis (Green, 
et al.  2005; Hides, et al., 2006). 
Social cognitive theory continues as a useful theoretical framework to study 
substance use (Bandura, 1977a, 1977b, 1997). It includes the confidence of users to 
resist temptation. This is typically conceptualized as the ability to resist or refuse a 
substance in specific situations, described as ‘drug refusal self-efficacy’ (e.g. Young, 
et al., 2007). Other subtypes of self-efficacy include the ability to avoid relapse (Litt, 
et al., 2005), coping self-efficacy (Sklar and Turner, 1999) and anticipatory efficacy 
to deal with relapse crisis situations (Sklar, et al., 1997). Additionally, judgments 
made generic to all drugs of abuse (Schell, et al., 2005), or a focus on self-efficacy for 
therapeutic goal attainment (Lozano, et al., 2006) have been described. These 
definitions have both strengths and weaknesses particularly with lower levels of 
dependence or abuse. Drug refusal self-efficacy (Young et al., 1991) makes fewer 
assumptions about the nature of drug use as it is not defined by relapse risk. This has 
broad applicability as a construct in survey work, prevention initiatives and also as a 
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clinical tool. The Drinking Refusal Self-efficacy Questionnaire (DRSEQ: Young, et 
al., 1991; Young and Oei, 1996) has three factors (Social Pressure self-efficacy, 
Opportunistic self-efficacy, Emotional Relief self-efficacy) with good validity and 
reliability (Oei, et al., 2005). The DRSEQ has been used widely in investigating the 
association between drinking refusal self-efficacy and drinking behavior. DRSEQ 
factors are associated with frequency of alcohol consumption in university students 
(Baldwin et al., 1993) and there is a confirmed association between DRSEQ factor 
scores and both frequency and volume of consumption (Connor et al., 2000; Young, 
et al., 2006). These findings are maintained across prospective studies (Connor, et al., 
2011; Young and Oei, 2000) .The DRSEQ differentiates problem/non-problem 
drinkers (Oei et al., 1998; Young, 1994) and high/ low risk community drinkers (Lee 
et al., 1999; Ricciardelli et al., 2001). It mediates the relationship between impulsivity 
and alcohol use in patients undergoing residential treatment (Gullo, et al., 2010). 
Cannabis specific self-efficacy scales are available. Stephens, et al., (1993) 
developed a self-efficacy measure for avoiding cannabis on 167 cannabis using adults. 
The scale was based on Marlatt and Gordon’s (1985) categories of relapse. The 19-
item scale applied a summary score with an internal reliability of .89. No further 
psychometric assessment was undertaken. After controlling for demographics and 
consumption, the total score was not associated with cannabis problems at baseline or 
post-treatment. A subsequent study (Stephens, et al., 1995) in 210 treatment seeking 
cannabis users confirmed the single factor solution of the measure. The cognitive-
behavioral based treatment improved reported self-efficacy beliefs post-intervention.  
The Cannabis Situational Confidence Questionnaire (modeled on Annis and 
Graham’s [1988] Smoking Situational Confidence Questionnaire) was purpose-built 
for a cannabis intervention study (n=229) by Copeland et al. (2001). Although no 
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psychometric testing was undertaken, the scale did demonstrate a significant 
proportion of patients used cannabis for stress relief. Adapting the smoking 
Situational Confidence Questionnaire, Burleson and Kaminer (2005) applied the same 
smoking factor structure as Annis and Graham. This structure was not validated 
through either exploratory or confirmatory factor analyses. Increased self-efficacy 
predicted cannabis abstinence. Litt and colleagues (2008) found that increasing self-
efficacy was the primary mechanism through which most effective treatments for 
cannabis dependence operate, irrespective of the specific approach (e.g., motivational 
interviewing, contingency management).  
A rigorously validated measure of cannabis refusal self-efficacy would  
benefit treatment evaluation and research. Recognizing the advantages of the DRSEQ 
(Young and Oei, 1996; Oei, et al, 2005), this study develops and validates a parallel 
Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ). 
Cannabis-related self-efficacy measures have not previously undergone 
comprehensive psychometric evaluation. Here we include both exploratory factor 
analysis and confirmatory factor analysis using structural equation modeling 
(Hopwood and Donellan, 2010; Tabachnick, and Fidell, 2007). Concurrent validity 
testing with levels of cannabis consumption and dependence severity is conducted to 
assess the clinical utility of the CRSEQ.  
 
2. Method 
2.1 Participants 
 Data were obtained from 1250 consecutive adult individuals who were 
referred for cannabis assessment as part of the Queensland Illicit Drug Diversion 
Initiative (QIDDI). The QIDDI is a Queensland Police diversion program for 
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individuals charged with cannabis-related offences. The program involves a two-hour 
comprehensive assessment of substance use and psychosocial functioning and 
incorporates a motivational interviewing component. Referral to further treatment is 
provided if indicated. 
The mean age of the sample was 27.21 years (SD = 8.56). There were 971 
(77.7%) males and 279 (22.3%) females. The majority of participants were born in 
Australia (1012; 81.0%) or New Zealand (94; 7.5%), with 42 (3.4%) identifying 
themselves as Indigenous Australians. In order to conduct exploratory factor analysis 
(EFA) and confirmatory factor analysis (CFA) on the new measure, data were 
randomly split (via SPSS select random cases function) into half with data from 625 
participants used for the EFA, and 625 participants for the CFA. Descriptive data 
regarding drug and alcohol use are reported separately for each sample below. 
 
2.2 Measures 
 2.2.1Demographics. Information regarding age, gender, martial status, level of 
education, employment, and country of origin were recorded. 
 2.2.2 Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) (Young and 
Kavanagh, 1997). The CRSEQ is a 28-item questionnaire assessing an individual’s 
belief in their ability to resist smoking cannabis across a range of situations. 
Participants are asked to rate their ability to resist smoking cannabis on a 6-point 
Likert-type scale ranging from 1 (I am very sure I could NOT resist smoking 
cannabis) to 6 (I am very sure I could resist smoking cannabis). Item content was 
adapted from the DRSEQ) (Young et al., 1991), a reliable and valid measure of self-
efficacy regarding refusal of alcohol in cued situations. The adaptation primarily 
involved substituting the word “drinking” for “smoking,” as well as removing items 
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deemed inappropriate when applied to cannabis, given its status as an illicit substance, 
or deemed to be of low relevance to cannabis use. 
 2.2.3 Severity of Dependence Scale-Cannabis (SDS-C) (Gossop et al., 1995). 
The SDS-C is a 5-item scale that measures the degree of dependence experienced by 
individuals who use different types of substances. The SDS-C is sensitive to severity 
of cannabis dependence (Swift et al., 2000). Using Australian normative data, the 
SDS-C cut-off for likely cannabis dependence is ≥ 2 (Swift et al., 1998). 
 2.3.4 Cannabis Consumption was clinically assessed by Masters and PhD 
qualified clinical psychologists (with between 2 and 25 years alcohol and drug 
treatment experience; M = 10.5 years) using a retrospective diary approach over the 
past week. If cannabis was not consumed in the past week, clinical staff assessed the 
typical weekly level of consumption for the respondent. For the purposes of this 
study, ‘joints’ (cannabis cigarette) were quantified as 0.25 grams of cannabis and 
‘cones’ (use of ‘bong’ or ‘pipe’), 0.10 grams of cannabis. 
 
2.3 Procedure 
 As part of the assessment protocol, individuals participating in the QIDDI 
program completed the CRSEQ and SDS-C. Human ethics approval was obtained for 
this study.  
 
3. Study 1: Exploratory Factor Analysis (EFA) of the Cannabis Refusal Self-
Efficacy Questionnaire (CRSEQ) (n= 625) 
All analyses were performed in SPSS (version 17). Of the original sample, 4 (0.6%) 
participants did not respond to at least 50% of CRSEQ items and were excluded, 
leaving 621 cases for analysis. The average age of participants was 26.88 (SD = 8.48) 
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years. There were 488 (78.6%) males and 133 (21.4%) females. Average weekly 
cannabis consumption was reported at 3.45 (SD = 5.28) grams and the average SDS-C 
score was 3.35 (SD = 3.25). Approximately 64% of participants met the SDS-C 
dependence criteria (≥ 2, Swift et al., 1998). The majority of participants (80.2%) 
reported alcohol use in the previous month. Participants reported an average of 7.08 
(SD = 8.31) drinking days in the past month, consuming an average of 85.69 (SD = 
146.83) grams of alcohol on each drinking day. A total of 367 (59.1%) participants 
were also current tobacco smokers, smoking an average of 11.55 (SD = 9.71) 
cigarettes per day. 
 
3.1 Principal Components Analysis 
Each of the 28 CRSEQ items had 17 (2.7%) or fewer cases with missing data. 
Therefore, the missing data (pairwise) correlation matrix was analyzed (Tabachnick 
and Fidell, 2007). An initial principal components analysis (PCA) with oblique (direct 
oblimin) rotation was used to estimate number of principal components and 
factorability of the correlation matrices. The Kaiser-Meyer-Olkin (KMO) measure of 
sampling adequacy was .97, suggesting suitable factorability of correlation matrices. 
This parallels the initial analysis of the DRSEQ (Young, et al., 1991). 
Three components with eigenvalues > 1 were identified and examination of 
the scree plot also suggested the presence of three principal components. Therefore, 
PCAs specifying 2, 3, and 4 components were conducted. Of these PCAs, the three-
component analysis provided the optimal solution in terms of percentage of variance 
explained, number of items per factor, and absence of cross-loadings. Extracted 
components were moderately-to-highly correlated, confirming the use of oblique 
rotation (direct oblimin; rs ranged from .47 to .67).  
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In total, the three extracted components accounted for 73.80% of the variance. 
Communalities suggested the three-component solution accounted for more than 50% 
of the variance in each item (range = .55 - .89). Component loadings revealed 11 
items significantly cross-loaded (≥ .30) on more than one component and were 
excluded from the final solution. Item 22 (“Within 30 minutes of getting out of bed”) 
and 23 (“When my medication side effects are bad”) were also removed because of 
poor response discrimination, and theoretical considerations.  
The PCAs were then re-run on the remaining 15 items. The result of these 
analyses also suggested a three-factor solution with oblique (direct oblimin) rotation 
was optimal. In total, the three extracted components accounted for 80.12% of the 
variance. Communalities suggested the three-component solution accounted for more 
than 60% variance in each item (ranging from .63 - .90). Item loadings are presented 
in Table 1. Based on the item loadings, the first component was labeled Emotional 
Relief self-efficacy, the second labeled Opportunistic self-efficacy, and the third 
labeled Social Facilitation self-efficacy. Table 1 also shows the three components 
were found to have high internal consistency. As with the DRSEQ, the three 
components of the CRSEQ were significantly inter-correlated (rs range from .55 to 
.71). In summary, initial validation of the CRSEQ suggests a three-component 
structure similar to the DRSEQ. Each of the extracted components has high internal 
reliability. 
_______________ 
Insert Table 1 here 
_______________ 
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4. Study 2: Confirmatory Factor Analysis (CFA) of the Cannabis Refusal Self-
Efficacy Questionnaire (CRSEQ) (n=625) 
Study 2 aimed to confirm the factor structure of the 15-item CRSEQ on an 
independent sample of cannabis users in treatment. The study also sought to establish 
the clinical utility of the measure by exploring its application to current cannabis use 
and dependence. 
All analyses were performed in SPSS and AMOS (version 17). Of the total 
625 participants, 480 (76.8%) were male and 145 (23.2%) female. The average age of 
participants was 27.51 (SD = 8.62) years. Average weekly cannabis consumption was 
reported at 3.89 (SD = 5.15) grams and the average SDS-C score was 3.16 (SD = 
3.17). Approximately 60% of participants met SDS-C criteria for cannabis 
dependence (≥ 2, Swift et al., 1998). The majority of participants (87.8%) reported 
alcohol use within the last month. Participants reported an average of 7.22 (SD = 
8.59) drinking days in the past month, consuming an average of 83.16 (SD = 84.86) 
grams of alcohol on each drinking day. A total of 360 (57.6%) participants were also 
current tobacco smokers, smoking an average of 11.77 (SD = 10.14) cigarettes per 
day. 
4.1 Model Estimation and Evaluation 
Confirmatory factor analysis (CFA) was conducted using maximum likelihood 
estimation. Model fit was evaluated in several ways. In accordance with the 
recommendations of Hu and Bentler (Bentler, 2007; Hu and Bentler, 1999), χ2 test 
was selected as a statistical test of model fit (α = .05). However, given the sensitivity 
of this test to trivial deviations from fit in large samples, the “normed” χ2 (χ2/df) was 
also utilized. Values of χ2/df between 1.00 and 3.00 are indicative of good fit. 
However, some researchers have argued values as high as 5.00 are acceptable (Kline, 
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2005). The comparative fit index (CFI) and root mean-square error of approximation 
(RMSEA) were also used to evaluate fit (Bentler, 2007). The following cut-offs were 
used for “good” fit: CFI ≥ .95 and RMSEA ≤ .06 (Hu and Bentler, 1999). For 
“acceptable” fit, cut-offs used were CFI ≥ .90 and RMSEA ≤ .10 (Hu and Bentler, 
1999). However, it should be noted that it is difficult to set specific criteria for the 
evaluation of model fit as fit indices are not equally effective across different 
conditions (Hu and Bentler, 1999; Marsh, et al., 2004). Therefore, the hypothesized 
model was compared to a non-hypothesized alternative. The Akaike Information 
Criterion (AIC) was examined to assist model comparison (Akaike, 1987). The AIC 
has no conventional cut-off. Instead, smaller values indicate a model is better-fitting 
and more parsimonious.  
 
4.2 Confirmatory Factor Analysis (CFA) 
Based on the results of exploratory factor analysis in Study 1, the 
hypothesized measurement model included Emotional Relief self-efficacy as latent 
variable with seven items as indicators, Opportunistic self-efficacy as a latent variable 
with five items as indicators, and Social Facilitation self-efficacy as a latent variable 
with three items as indicators (see Table 1 for item listing). The three latent variables 
were hypothesized to “load” or serve as indicators of a higher-order Cannabis Refusal 
Self-Efficacy latent factor.  
No variable was missing more than 5% data (range: 0.32 – 3.04%). Missing 
data was imputed using Full Information Maximum Likelihood (FIML) estimation, an 
optimal strategy for handling missing data (Graham, 2009). Six items were found to 
have significantly skewed distributions and were transformed using square-root or log 
transformation before testing the model (Kline, 2005). The hypothesized 
 12 
measurement model was found to provide an overall “acceptable-to-poor” fit to the 
data (see Table 2, Model 1). Closer inspection of model output suggested the fit of the 
model could be improved by specifying a residual covariance between item 14 
(“When I am feeling lonely”) and item 15 (“When I feel sad”). That is, variance in 
these two items not explained by the latent Emotional Relief self-efficacy variable 
was significantly related. Given the relatively low standardized loading of item 14 
(.87), and its skewed distribution, this item was removed from the model.  
The revised model, presented in Figure 1, was found to provide an overall 
“acceptable-to-good” fit to the data (see Table 2, Model 2) and change in AIC scores 
suggested it provided a better fit than the originally specified model. All items loaded 
highly on their respective factors. As post-hoc model modifications were made, a 
correlation between the item loadings of the original and revised models was 
conducted, r (623) = .997, p < .001. This showed that the model parameters were only 
marginally changed. The revised measurement model was compared to a non-
hypothesized, alternative model in which all items were specified to serve as 
indicators of a single Cannabis Refusal Self-Efficacy factor. This model was found to 
provide a poor fit to the data (see Table 2, Model 3). This result, combined with the 
revised model’s lower AIC, suggested the revised three-factor model provided a better 
fit to the data.  
_______________ 
Insert Table 2 here 
_______________ 
_______________ 
Insert Figure 1 here  
_______________ 
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4.3 Gender Invariance 
The influence of gender on parameter estimates and model fit was examined in 
a multi-group CFA. The revised three-factor multi-group model provided a 
“moderately good” fit to the data (see Table 2, Model 4). Invariance testing was 
conducted to evaluate whether there were any gender differences in the measurement 
model (e.g., smaller factor loadings in males). This was performed by constraining all 
parameters, factor variances, and error variances to equality across gender. The fit of 
the constrained (invariance) model was not significantly different to the unconstrained 
model (Δχ2 [31] = 40.15, p > .05), suggesting invariance across gender. That is, there 
were no significant differences in the factor structure of the CRSEQ between male 
and female cannabis users. Similarly, independent-groups t test revealed no mean 
differences on any of the subscales across gender (α = .05). Normative data for the 14-
item CRSEQ are presented in Table 3. This table also shows that the internal 
reliability of the CRSEQ subscales and total score were good-to-excellent. 
 
_______________ 
Insert Table 3 here 
_______________ 
 
4.4 Prediction of cannabis use and dependence 
 In order to explore the utility of the CRSEQ in predicting current cannabis use 
and dependence, a path model was tested in which each of the three CRSEQ subscales 
were hypothesized to contribute to prediction (see Figure 2). Cannabis use was 
operationalized as participants’ reported average weekly cannabis use (in grams), and 
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cannabis dependence was operationalized as participants’ SDS-C total score. Age and 
gender were also included in the model as covariates, and weekly cannabis used was 
also hypothesized to predict level of dependence. The hypothesized model showed a 
very good fit to the data, χ2 (7) = 18.68, p = .01, χ2/df = 2.67, CFI = .99, RMSEA = 
.05, AIC = 74.68. As predicted, all CRSEQ subscales contributed unique variance to 
the prediction of weekly cannabis use. In total, the CRSEQ accounted for 22% of the 
variance in weekly cannabis use, indicating a medium-to-large effect size. Consistent 
with the findings of Copeland et al. (2001), Emotional Relief Self-Efficacy was the 
only significant predictor of cannabis dependence (unstandarized coefficient = -0.08, 
p = .003). However, there was a non-significant trend for Opportunistic Self-Efficacy 
to predict cannabis dependence as well (unstandarized coefficient = -0.06, p = .06). In 
total, the model accounted for 20% variance in severity of cannabis dependence. 
_______________ 
Insert Figure 2 here  
_______________ 
 
5. Discussion 
These two studies provide strong support for the validity of a new measure of 
cannabis refusal self-efficacy. The findings of Study 1 revealed a three-factor 
structure for the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ): Emotional 
Relief self-efficacy, Opportunistic self-efficacy, and Social Facilitation self-efficacy. 
This factor structure is broadly consistent with that of the established Drinking 
Refusal Self-Efficacy Questionnaire (DRSEQ; Young et al., 1991) and the Heroin 
Refusal Self-Efficacy Questionnaire (Young, et al.,, 2006). Each of the three factors 
has good internal reliability. 
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Study 2 confirmed the three-factor structure of the CRSEQ in an independent 
sample of cannabis users in treatment. Results of Study 2 showed no gender 
differences in the structure or mean scores of the measure. This study also 
demonstrated the predictive value of the measure. Each of the three subscales 
uniquely predicted weekly cannabis use. Therefore, while the three subcomponents of 
cannabis refusal self-efficacy are related, they represent distinct constructs. This is 
supported by results of the EFA and CFA, which suggested a three-factor structure 
was optimal. 
Results of the path analysis also confirm that Emotional Relief refusal self-
efficacy plays a more prominent role in severity of cannabis dependence, after 
controlling for weekly consumption. While low Emotional Relief self-efficacy is also 
important in predicting early drinking behavior (eg Young, et al., 2007), for those 
with established alcohol problems, low Opportunistic drinking refusal self-efficacy is 
a more powerful predictor. This difference may reflect pharmacological and social 
learning differences as well as the environmental context of substance use given that 
the opportunities to use an illicit drug in many settings are restricted. Poor self-
efficacy to resist cannabis during heightened negative affect is more strongly related 
to dependence than availability of the drug or its (perceived) ability to facilitate social 
interactions. These results are consistent with Copeland et al.’s (2001) finding that 
stress relief is an important motivator of cannabis use in dependent persons. The 
potential implications for treatment are that increasing an individual’s confidence to 
manage negative affect may be a greater priority in those with more severe cannabis 
dependence. This could be achieved through behavioral strategies aimed at building a 
patient’s repertoire of coping skills, or focusing treatment on comorbid mood or 
anxiety disorders (DeMarce, et al., 2005). While the cross-sectional associations 
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reported here cannot establish that a change in self-efficacy would result in a change 
in cannabis use or dependence, there is evidence suggesting that effective 
psychosocial treatments primarily operate through improving self-efficacy (Litt et al., 
2008). 
This research has some limitations. First, the sample of adult, court-referred 
cannabis users may not be generalizable to all clinical samples seeking treatment. 
Second, cannabis use was measured over the past week and monthly consumption or 
biological drug screening data would have provided a more robust assessment. Third, 
cross-sectional data limits the extent one can draw casual inferences. Further 
prospective studies are required to determine the influence of cannabis refusal self-
efficacy on consumption and dependence severity. There are also several key 
advantages to this work relating to a large clinical sample and a robust psychometric 
evaluation involving CFA and EFA.  
The CRSEQ is a clinically useful, validated assessment to assist with 
treatment planning and pre-and-post treatment measurement. Prospective studies are 
required to assess the CRSEQ’s utility as a prognostic tool for cannabis treatment 
outcome. 
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Figure Legends 
 
Figure 1. Confirmatory Factor Analysis (CFA) of the Cannabis Refusal Self-Efficacy 
Questionnaire (CRSEQ; N = 625). 
Note. Ellipses represent latent constructs or factors, and rectangles indicate measured 
variables (items). Circles (e) reflect residuals or (d) disturbances; numbers above or 
near endogenous variables represent the amount of variance explained (R2). 
Standardized parameter estimates are presented and all are statistically significant at p 
< .05. 
 
 
Figure 2. Path model of the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) 
predicting current cannabis use and dependence severity (N = 625). 
Note. Ellipses represent latent constructs or factors, and rectangles indicate measured 
variables (items). Circles (e) reflect residuals or (d) disturbances; numbers above or 
near endogenous variables represent the amount of variance explained (R2). 
Standardized parameter estimates are presented. SDS-C = Severity of Dependence 
Scale-Cannabis. 
*p < .05; **p < .01; ***p < .001; †p = .06. 
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Table 1  
Psychopathology 
 Mean SD 
Study 1: Exploratory Factor Analysis (N = 621) 
GHQ-28 Somatic Symptoms 0.95 1.52 
GHQ-28 Anxiety 1.09 1.80 
GHQ-28 Social Dysfunction 0.80 1.54 
GHQ-28 Depression 1.62 3.72 
Brief Psychiatric Rating Scale Total 24.21 6.79 
Study 2: Confirmatory Factor Analysis (N = 625) 
GHQ-28 Somatic Symptoms 0.92 1.51 
GHQ-28 Anxiety 1.07 1.69 
GHQ-28 Social Dysfunction 0.72 1.38 
GHQ-28 Depression 1.66 3.64 
Brief Psychiatric Rating Scale Total 1.91 3.75 
Note. GHQ-28 = General Health Questionnaire (28-item version). 
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Table 2 
Item loadings from principal components analysis (PCA) of the Cannabis Refusal 
Self-Efficacy Questionnaire (N = 621) 
Item 
Emotional 
Relief 
Opportunistic Social 
Facilitation 
12. When I feel upset 1.00   
13. When I feel down .97   
15. When I feel sad .96   
9. When I am ashamed .89   
11. When I am worried .87   
14. When I am feeling lonely .82   
8. When I feel restless .77   
18. When my friends are smoking  .92  
4. When someone offers me a smoke  
 
.92  
3. When I am at a party  .83  
28. When I have been drinking  .80  
16. When my spouse or partner is 
smoking  
 
.73  
27. When I am going to meet or am 
meeting people for the first time  
 
 
 .87 
5. When I want to feel more 
confident  
 
 .83 
10. When I want to feel more 
accepted by friends  
 
.82 
    
% variance 65.14 8.46 6.5 
Cronbach’s α .97 .91 .84 
    
Mean 28.52 17.89 14.86 
Standard deviation (SD) 11.25 7.51 3.71 
Note. Item loadings lower than .30 not shown for clarity of exposition. 
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Table 3 
Fit Indices for Confirmatory Factor Analysis of the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ; N = 625) 
Model χ2 (df) χ2/df CFI RMSEA AIC ΔAIC 
1. Hypothesised measurement model 561.45* (87) 6.45 .95 .09 657.45  
2. Revised measurement model 365.96* (74) 4.95 .96 .08 455.96  
3. Non-hypothesized, one-factor 
 alternative model 
1481.14* (77) 19.24 .83 .17 1565.14  
4. Multi-group model comparing 
 gender 
503.61* (148) 3.40 .96 .06 683.61  
 Difference between  
 Model 2 & Model 1 
     201.49 
 Difference between  
 Model 3 & Model 2 
     1109.18 
Note. CFI = Comparative Fit Index; RMSEA = Root Mean-Square Error of Approximation; AIC = Akaike Information Criterion 
* p < .05. 
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Table 4  
Normative data for the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ; N = 
625) 
 α Mean SD 
CRSEQ: Emotional Relief (6 items) .96 23.82 9.61 
CRSEQ: Opportunistic (5 items) .91 17.87 7.63 
CRSEQ: Social Facilitation (3 items) .79 14.94 3.50 
CRSEQ Total Score (14 items) .95 56.88 18.68 
 
 
